REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ipharm Polska Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Beverage Manufacturing | Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Food Services and Drinking Places
Full name: Ipharm Polska Sp. z o.o. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Ipharm Polska Sp. z o.o. is an enterprise based in Poland. Its main office is in Krakow. It operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on February 16, 2017. A negative growth of 33.11% was recorded in its total assets.

Headquarters
Ul. Berka Joselewicza 2/1
Krakow; Malopolskie; Postal Code: 31-051

Contact Details: Purchase the Ipharm Polska Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ipharm Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ipharm Polska Sp. z o.o. report to view the information.
Incorporation Date:
February 16, 2017
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
35%
Company Performance
Financial values in the chart are available after Ipharm Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
N/A
Total operating revenue
N/A
Operating profit (EBIT)
89.47%▲
Net Profit (Loss) for the Period
89.54%▲
Total assets
-33.11%▼
Total equity
-0.14%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-1.2%▼
Debt to Equity Ratio
0.02%▲
Quick Ratio
-11.12%▼
Cash Ratio
-0.89%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo